![Yu-Kyeong Hwang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yu-Kyeong Hwang
Director/Miembro de la Junta en GC CELL CORPORATION .
Cargos activos de Yu-Kyeong Hwang
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
GC CELL CORPORATION | Director/Miembro de la Junta | 01/09/2014 | - |
Corporate Officer/Principal | 01/09/2014 | - |
Historial de carrera de Yu-Kyeong Hwang
Antiguos cargos conocidos de Yu-Kyeong Hwang.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Artiva Biotherapeutics, Inc.
![]() Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Director/Miembro de la Junta | 01/02/2019 | 01/04/2022 |
GREEN CROSS CELL CORPORATION | Director/Miembro de la Junta | 01/03/2013 | - |
Formación de Yu-Kyeong Hwang.
Indiana University | Undergraduate Degree |
Estadísticas
Internacional
Corea del Sur | 3 |
Estados Unidos | 3 |
Operativa
Director/Board Member | 3 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
GC CELL CORPORATION | Health Technology |
Empresas privadas | 2 |
---|---|
GREEN CROSS CELL Corp.
![]() GREEN CROSS CELL Corp. BiotechnologyHealth Technology GREEN CROSS CELL Corp. engages in the provision of anti-cancer immunotherapy. It operates through the following businesses: Cancer Immunotherapy, Cord Blood Cryopreservation, and Other Services. The company was founded on September 17, 1992 and is headquartered in Yongin-si, South Korea. | Health Technology |
Artiva Biotherapeutics, Inc.
![]() Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Yu-Kyeong Hwang
- Experiencia